FI106457B - Förfarande för framställning av terapeutiskt aktiva 4-amino-substituerade 2-azabicyklo[3.3.1]nonanderivat - Google Patents
Förfarande för framställning av terapeutiskt aktiva 4-amino-substituerade 2-azabicyklo[3.3.1]nonanderivat Download PDFInfo
- Publication number
- FI106457B FI106457B FI20000085A FI20000085A FI106457B FI 106457 B FI106457 B FI 106457B FI 20000085 A FI20000085 A FI 20000085A FI 20000085 A FI20000085 A FI 20000085A FI 106457 B FI106457 B FI 106457B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- phenyl
- azabicyclo
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Claims (2)
1. Förfarande för framställning av terapeutiskt ak-tiva 4-amino-substituerade 2 azabicyklo[3.3.1]- 5 nonanderivat med formeln (I) (CH2)3 \ r3 '"H * H X —Ph / H väri Ph är fenyl och R3 är fenyl som är substituerad med en (Ci-C6) -alkoxygrupp, och av dess farmaceutiskt ac-10 ceptabla salter, kännetecknat av att (a) förening med formeln (III) (CH2)3 \ ν^\ζη r3 |H ^ Cbz H Ph III väri Ph och R3 är ovan definierade och Cbz är benzy-15 loxykarbonyl, omsätts med ammoniumformiat i närvaro av en • - palladium-karbonkatalyt, och (b) eventuellt omvandlas den erhällna förening med formeln I tili sitt farmaceutiskt acceptabla sait.
2. Förfarande enligt patentkravet 1, känne-20 tecknat av att man framställer (3RS,4RS)-3-fenyl-4- * (2-metoxybenzyl)amino-2-azabicyklo-[3.3.1]nonan.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88511092A | 1992-05-18 | 1992-05-18 | |
US88511092 | 1992-05-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20000085A FI20000085A (sv) | 2000-01-17 |
FI106457B true FI106457B (sv) | 2001-02-15 |
Family
ID=25386157
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI932229A FI932229A (fi) | 1992-05-18 | 1993-05-17 | Azabicykliska bryggderivat |
FI20000085A FI106457B (sv) | 1992-05-18 | 2000-01-17 | Förfarande för framställning av terapeutiskt aktiva 4-amino-substituerade 2-azabicyklo[3.3.1]nonanderivat |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI932229A FI932229A (fi) | 1992-05-18 | 1993-05-17 | Azabicykliska bryggderivat |
Country Status (11)
Country | Link |
---|---|
US (1) | US5498614A (sv) |
EP (1) | EP0641328B1 (sv) |
JP (1) | JP2757234B2 (sv) |
AT (1) | ATE209186T1 (sv) |
CA (1) | CA2134964C (sv) |
DE (1) | DE69331190T2 (sv) |
DK (1) | DK0641328T3 (sv) |
ES (1) | ES2164657T3 (sv) |
FI (2) | FI932229A (sv) |
PT (1) | PT641328E (sv) |
WO (1) | WO1993023380A1 (sv) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2700472B1 (fr) | 1993-01-19 | 1995-02-17 | Rhone Poulenc Rorer Sa | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2. |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
EP0653208A3 (en) * | 1993-11-17 | 1995-10-11 | Pfizer | Substance P antagonists for the treatment or prevention of sunburn. |
EP0659409A3 (en) * | 1993-11-23 | 1995-08-09 | Pfizer | Substance P antagonists for the inhibition of angiogenesis. |
EP0655246A1 (en) * | 1993-11-30 | 1995-05-31 | Pfizer Inc. | Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria |
US5696267A (en) * | 1995-05-02 | 1997-12-09 | Schering Corporation | Substituted oximes, hydrazones and olefins as neurokinin antagonists |
US5688960A (en) * | 1995-05-02 | 1997-11-18 | Schering Corporation | Substituted oximes, hydrazones and olefins useful as neurokinin antagonists |
JP2000500468A (ja) * | 1995-11-13 | 2000-01-18 | スミスクライン・ビーチャム・コーポレイション | 血液調節化合物 |
US5789422A (en) * | 1996-10-28 | 1998-08-04 | Schering Corporation | Substituted arylalkylamines as neurokinin antagonists |
US7101547B1 (en) | 1999-01-22 | 2006-09-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies |
AU2572800A (en) * | 1999-02-18 | 2000-09-04 | Hisamitsu Pharmaceutical Co. Inc. | Morphan derivatives or salts thereof and medicinal compositions containing the same |
US7541357B2 (en) | 2004-07-15 | 2009-06-02 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
ATE550019T1 (de) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs |
GEP20125566B (en) | 2005-07-15 | 2012-07-10 | Amr Technology Inc | Aryl-and heteroaryl-substituded tetrahydro-benzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
AU2006297443B2 (en) | 2005-09-29 | 2010-08-12 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CA2664113C (en) | 2006-09-22 | 2013-05-28 | Merck & Co., Inc. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
JP4611444B2 (ja) | 2007-01-10 | 2011-01-12 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | ポリ(adp−リボース)ポリメラーゼ(parp)阻害剤としてのアミド置換インダゾール |
CA2682727C (en) | 2007-04-02 | 2016-03-22 | Banyu Pharmaceutical Co., Ltd. | Indoledione derivative |
EP3103791B1 (en) | 2007-06-27 | 2018-01-31 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
US8598184B2 (en) | 2008-03-03 | 2013-12-03 | Tiger Pharmatech | Protein kinase inhibitors |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
WO2010132487A1 (en) | 2009-05-12 | 2010-11-18 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
PE20120373A1 (es) | 2009-05-12 | 2012-05-17 | Albany Molecular Res Inc | 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina |
CN102458123A (zh) | 2009-05-12 | 2012-05-16 | 阿尔巴尼分子研究公司 | 芳基、杂芳基和杂环取代的四氢异喹啉及其用途 |
JP5099731B1 (ja) | 2009-10-14 | 2012-12-19 | メルク・シャープ・アンド・ドーム・コーポレーション | p53活性を増大する置換ピペリジン及びその使用 |
EP2584903B1 (en) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
US8518907B2 (en) | 2010-08-02 | 2013-08-27 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
DK2606134T3 (da) | 2010-08-17 | 2019-07-22 | Sirna Therapeutics Inc | RNA-Interferens-formidlet inhibering af hepatitis-B-virus (HBV)-genekspression ved hjælp af kort interfererende nukleinsyre (siNA) |
EP2608669B1 (en) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
DK2632472T3 (en) | 2010-10-29 | 2018-03-19 | Sirna Therapeutics Inc | RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA) |
EP2654748B1 (en) | 2010-12-21 | 2016-07-27 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
US20140045847A1 (en) | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
EP3358013B1 (en) | 2012-05-02 | 2020-06-24 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
RU2660429C2 (ru) | 2012-09-28 | 2018-07-06 | Мерк Шарп И Доум Корп. | Новые соединения, которые являются ингибиторами erk |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神***病を処置するための方法および組成物 |
AU2013352568B2 (en) | 2012-11-28 | 2019-09-19 | Merck Sharp & Dohme Llc | Compositions and methods for treating cancer |
ES2707305T3 (es) | 2012-12-20 | 2019-04-03 | Merck Sharp & Dohme | Imidazopiridinas sustituidas como inhibidores de HDM2 |
WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
EP3706742B1 (en) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
EP3833667B1 (en) | 2018-08-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3560510A (en) * | 1969-03-05 | 1971-02-02 | Aldrich Chem Co Inc | 2-benzhydrylquinuclidines |
CA1160229A (en) * | 1979-03-13 | 1984-01-10 | Pieter T. Haken | Pyridyliminomethylbenzene derivatives |
CA1231710A (en) * | 1979-07-19 | 1988-01-19 | Haken Pieter Ten | Heterocyclic compounds having fungicidal, herbicidal and plant-growth regulating properties |
EP0100158A3 (en) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters |
US4552960A (en) * | 1983-06-20 | 1985-11-12 | Eli Lilly And Company | Fungicidal amines |
US4680283A (en) * | 1984-09-26 | 1987-07-14 | Merck & Co., Inc. | Analogs of substance P and eledoisin |
MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
UA41251C2 (uk) * | 1990-01-04 | 2001-09-17 | Пфайзер, Інк. | Гідровані азотвмісні гетероциклічні сполуки, похідні піперидину, фармацевтична композиція та спосіб пригнічення активності речовини р в організмі |
EP0532527B1 (en) * | 1990-06-01 | 1994-11-09 | Pfizer Inc. | 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them |
EP0540526B1 (en) * | 1990-07-23 | 1994-12-28 | Pfizer Inc. | Quinuclidine derivatives |
DK0550635T3 (da) * | 1990-09-28 | 1995-09-04 | Pfizer | Cykliske forbindelser med kondeserede ringe, som er analoger til nitrogenholdige ikke-aromatiske het erocykliske forbindelser |
US5138060A (en) * | 1991-01-03 | 1992-08-11 | Pfizer Inc. | Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
HUT65612A (en) * | 1991-01-10 | 1994-07-28 | Pfizer | Process n-alcyl-quinuclidinium salts of p-antagonistic activity |
DK0573522T3 (da) * | 1991-03-01 | 1995-03-06 | Pfizer | 1-Azabicyclo(3,2,2)nonan-3-aminderivater |
CZ293955B6 (cs) * | 1991-03-26 | 2004-08-18 | Pfizeráinc | Postup přípravy substituovaných piperidinů |
DE69213451T2 (de) * | 1991-06-20 | 1997-01-09 | Pfizer | Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen |
TW202432B (sv) * | 1991-06-21 | 1993-03-21 | Pfizer |
-
1993
- 1993-02-23 AT AT93906038T patent/ATE209186T1/de not_active IP Right Cessation
- 1993-02-23 US US08/335,726 patent/US5498614A/en not_active Expired - Fee Related
- 1993-02-23 JP JP5520178A patent/JP2757234B2/ja not_active Expired - Fee Related
- 1993-02-23 ES ES93906038T patent/ES2164657T3/es not_active Expired - Lifetime
- 1993-02-23 WO PCT/US1993/001429 patent/WO1993023380A1/en active IP Right Grant
- 1993-02-23 DE DE69331190T patent/DE69331190T2/de not_active Expired - Fee Related
- 1993-02-23 CA CA002134964A patent/CA2134964C/en not_active Expired - Fee Related
- 1993-02-23 EP EP93906038A patent/EP0641328B1/en not_active Expired - Lifetime
- 1993-02-23 DK DK93906038T patent/DK0641328T3/da active
- 1993-02-23 PT PT93906038T patent/PT641328E/pt unknown
- 1993-05-17 FI FI932229A patent/FI932229A/fi unknown
-
2000
- 2000-01-17 FI FI20000085A patent/FI106457B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69331190D1 (de) | 2002-01-03 |
JP2757234B2 (ja) | 1998-05-25 |
DK0641328T3 (da) | 2002-05-21 |
EP0641328A1 (en) | 1995-03-08 |
DE69331190T2 (de) | 2002-04-18 |
FI20000085A (sv) | 2000-01-17 |
CA2134964C (en) | 1997-12-30 |
ES2164657T3 (es) | 2002-03-01 |
EP0641328B1 (en) | 2001-11-21 |
CA2134964A1 (en) | 1993-11-25 |
PT641328E (pt) | 2002-04-29 |
US5498614A (en) | 1996-03-12 |
JPH07503483A (ja) | 1995-04-13 |
ATE209186T1 (de) | 2001-12-15 |
WO1993023380A1 (en) | 1993-11-25 |
FI932229A0 (fi) | 1993-05-17 |
FI932229A (fi) | 1993-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI106457B (sv) | Förfarande för framställning av terapeutiskt aktiva 4-amino-substituerade 2-azabicyklo[3.3.1]nonanderivat | |
AU651145B2 (en) | Fused ring analogs of nitrogen containing nonaromatic heterocycles | |
EP0594636B1 (en) | 3-aminopiperidine derivatives and related nitrogen containing heterocycles | |
KR100214905B1 (ko) | 퀴누클리딘 유도체 | |
JP2535134B2 (ja) | 縮合三環式窒素含有複素環 | |
US5688804A (en) | 3-Benzylamino-2-phenyl-piperidine derivatives as substance P receptor antagonists | |
EP0668863B1 (en) | Quinuclidine derivative as substance p antagonist | |
RU2114848C1 (ru) | Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ ингибирования действия вещества р у млекопитающих | |
PL164244B1 (en) | Method of obtaining novel heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |